Prevalent tuberculosis at HIV diagnosis in Rio de Janeiro, Brazil: The TB/HIV in Rio (THRio) cohort

Journal of Acquired Immune Deficiency Syndromes

Volumn 67, Issue 1, 2014, Pages 98-101

  Saraceni, Valeria ^a   Cohn, Silvia ^b   Cavalcante, Solange C ^a,c   Pacheco, Antonio G F ^c   Moulton, Lawrence H ^b,d   Chaisson, Richard E ^b,d   Durovni, Betina ^a,e   Golub, Jonathan E ^b,d  

^a Health Secretariat of Rio de Janeiro City   (Brazil)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

antiretroviral therapy; HIV AIDS; survival; tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAZARD RATIO; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; VIRUS LOAD; CLUSTER ANALYSIS; EPIDEMIOLOGY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; REGRESSION ANALYSIS; TUBERCULOSIS; VIROLOGY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; CD4 LYMPHOCYTE COUNT; CLUSTER ANALYSIS; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; TUBERCULOSIS; VIRAL LOAD;

EID: 84906087478     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000247     Document Type: Article

References (34)

1. Galvão J. Brazil and access to HIV/AIDS drugs: a question of human rights and public health. Am J Public Health. 2005;95:1110-1116.
2. Grangeiro A, Escuder MM, Menezes PR, et al. Late entry into HIV care: estimated impact on AIDS mortality rates in Brazil, 2003-2006. PLoS One. 2011;6:e14585.
3. Althoff KN, Gange SJ, Klein MB, et al. Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis. 2010;50:1512-1520.
4. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1989;38(suppl 5):1-9.
5. Date AA, Vitoria M, Granich R, et al. Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV. Bull World Health Organ. 2010;88:253-259.
6. Guidelines for Intensified Tuberculosis Case-finding and Isoniazid Preventive Therapy for People Living With HIV in Resource-Constrained Settings. Geneva, Switzerland: WHO; 2011. Available at: http://www. who.int/hiv/pub/tb/ 9789241500708/en/index.html. October 4, 2011.
7. Suthar AB, Lawn SD, del Amo J, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-Analysis. PLoS Med. 2012;9:e1001270.
8. Comstock GW, Baum C, Snider DE Jr. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis. 1979;119:827-830.
9. Akolo C, Adetifa I, Shepperd S, et al. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010; CD000171.
10. Golub JE, Saraceni V, Cavalcante SC, et al. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS. 2007;21:1441-1448.
11. de Pinho AM, Santoro-Lopes G, Harrison LH, et al. Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil. AIDS. 2001;15:2129-2135.
12. Jamal LF, Moherdaui F. Tuberculosis and HIV infection in Brazil: magnitude of the problem and strategies for control. Rev Saude Publica. 2007;41(suppl 1):104-110. Accessed April 18, 2014.
13. Boletim Epidemiológico. Ministério da Saúde. Secretaria de Vigilância em Saúde. 2014. Available at: http://portalsaude.saude.gov.br/images/pdf/2014/abril/10/Boletim-Tuberculose- 2014.pdf.
14. Soares ECC, Saraceni V, Lauria LM, et al. Tuberculosis as a disease defining acquired immunodeficiency syndrome: ten years of surveillance in Rio de Janeiro, Brazil. J Bras Pneumol. 2006;32:444-448.
15. Saraceni V, King BS, Cavalcante SC, et al. Tuberculosis as primary cause of death among AIDS cases in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis. 2008;12:769-772.
16. Conde MB, Melo FAF, Marques AMC, et al. III Diretrizes para Tuber-culose da Sociedade Brasileira de Pneumologia e Tisiologia. J Bras Pneumol (Online). 2009;35:1018-1048. Available at: http://www.scielo.br/scielo.php?script=sci- Arttext&pid=S1806-37132009001000011&lng=pt&nrm=iso& tlng=pt. Accessed August 17, 2011.
17. Saraceni V, Pacheco AG, Golub JE, et al. Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil. Braz J Infect Dis. 2011;15:249-252.
18. Moulton LH, Golub JE, Durovni B, et al. Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention. Clin Trials. 2007;4:190-199.
19. Durovni B, Saraceni V, Moulton LH, et al. Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial. Lancet Infect Dis. 2013;13: 852-858.
20. Pacheco AG, Saraceni V, Tuboi SH, et al. Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in Brazil. Am J Epidemiol. 2008;168:1326-1332.
21. Schechter M, Pacheco AG. Late diagnosis of HIV infection in Brazil despite over 15 years of free and universal access to treatment. AIDS Res Hum Retroviruses. 2012;28:1541-1542.
22. Grangeiro A, Escuder MM, Pereira JC. Late entry into HIV care: lessons from Brazil, 2003 to 2006. BMC Infect Dis. 2012;12:99.
23. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860.
24. Grinsztejn B, Veloso VG, Pilotto JH, et al. Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil. J Acquir Immune Defic Syndr. 2007;45:515-520.
25. Santoro-Lopes G, de Pinho AMF, Harrison LH, et al. Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy. Clin Infect Dis. 2002;34:543-546.
26. Havlir DV, Kendall MA, Ive P, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011;365:1482-1491.
27. Abdool Karim SS, Naidoo K, Grobler A, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011;365:1492-1501.
28. Dheda K, Lampe FC, Johnson MA, et al. Outcome of HIV-Associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis. 2004;190:1670-1676.
29. López-Gatell H, Cole SR, Margolick JB, et al. Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence. AIDS. 2008;22:1869-1873.
30. Gupta A, Wood R, Kaplan R, et al. Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa. PLoS One. 2013;8:e55824.
31. Lawn SD, Wilkinson RJ, Lipman MC, et al. Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy. Am J Respir Crit Care Med. 2008;177:680-685.
32. Granich R, Getahun H, Hirnschall G, et al. Hurry up and wait? Accelerating access to the Three I's for HIV-TB. Int J Tuberc Lung Dis. 2012; 16:853-854.
33. WHO-3 I's-Meeting-Report pdf (Online). Geneva, Switzerland: WHO;, 2011. Available at: http://www.who.int/hiv/pub/meetingreports/WHO-3Is- meeting-report.pdf Accessed October 17, 2011.
34. Nemes M, Melchior R, Basso C, et al. The variability and predictors of quality of AIDS care services in Brazil. BMC Health Serv Res. 2009;9:51.